Krish Patel

Also affiliated with University of California, Berkeley

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multiple Myeloma and Chronic Kidney Disease–Related Mortality, 1999–2023: A Population-Based Time-Trend Analysis

ASIDE Internal Medicine(2025)10.71079/aside.im.120125291

Top 78%

0.104DataRank

Top 78%1 citations

Mohamed Fawzi Hemida, Amro Ali, Raveen Mujeeb, Mohammad Rayyan Faisal, Mahmoud Tablawy +12 more

Papers

Driven by 13 papers — median percentile 22. Top paper: “Outcomes of COVID-19 in patients with CLL: a multicenter international experience”.

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Blood(2020)10.1182/blood.2020006965

N/A

13.4DataRank · unranked

318 citations

Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori A. Leslie, John M. Pagel +57 more

Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial

The Lancet(2025)10.1016/s0140-6736(24)02462-0

N/A

0.730DataRank · unranked

129 citations

Veronika Bachanova, Krish Patel, Jae H Park, Ian Flinn, Peter A Riedell +12 more

Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN

Blood(2025)10.1182/blood.2024024476

N/A

0.710DataRank · unranked

42 citations

Miklós Egyed, Wojciech Jurczak, Alan P Skarbnik, Krish Patel, Ian W. Flinn +22 more

Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia

Blood(2025)10.1182/blood.2024027009

N/A

0.452DataRank · unranked

6 citations

Bastien Nguyen, Sai Prasad Desikan, Helen Won, Shady I. Tantawy, Samuel McNeely +22 more

Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study

The Lancet Haematology(2025)10.1016/s2352-3026(25)00142-5

N/A

0.434DataRank · unranked

17 citations

Januario Castro, Aaron Goodman, Veronika Bachanova, Manali Kamdar, Farrukh T Awan +11 more

Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma

Advances in Therapy(2024)10.1007/s12325-024-02917-7

N/A

0.434DataRank · unranked

17 citations

Armin Ghobadi, Richard Maziarz, Krish Patel, Hil Hsu, Zihao Liu +4 more

Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies

Acta Haematologica(2024)10.1159/000539587

N/A

0.104DataRank · unranked

1 citations

Catherine C. Coombs, Nirav N. Shah, Wojciech Jurczak, Jennifer A. Woyach, Chan Y. Cheah +16 more

Multiple Myeloma and Chronic Kidney Disease–Related Mortality, 1999–2023: A Population-Based Time-Trend Analysis

ASIDE Internal Medicine(2025)10.71079/aside.im.120125291

Top 78%

0.104DataRank

Top 78%1 citations

Mohamed Fawzi Hemida, Amro Ali, Raveen Mujeeb, Mohammad Rayyan Faisal, Mahmoud Tablawy +12 more

Vinorelbine causes a neuropathic pain-like state in mice via STING and MNK1 signaling associated with type I interferon induction

iScience(2024)10.1016/j.isci.2024.108808

N/A

0DataRank · unranked

12 citations

Keerthana Natarajan, Eric T. David, Krish Patel, Abhira Ravirala, Theodore J. Price +1 more

Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B‐Cell Lymphoma

American Journal of Hematology(2024)10.1002/ajh.27548

N/A

0DataRank · unranked

13 citations

Reid W. Merryman, Yan Wang, Charles Gaulin, Evandro D. Bezerra, Timothy Voorhees +16 more

Patient-Reported Outcomes (PROs) Among Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Pirtobrutinib: Analysis from the BRUIN Phase 1/2 Study

Blood(2023)10.1182/blood-2023-186145

N/A

0DataRank · unranked

0 citations

Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Lindsey E. Roeker, Krish Patel +17 more

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial

Haematologica(2024)10.3324/haematol.2024.285754

N/A

0DataRank · unranked

13 citations

Michael Wang, Lindsey E. Roeker, Krish Patel, Jennifer A. Woyach, William G. Wierda +30 more

Use of convalescent plasma in hospitalized patients with COVID-19: case series

Blood(2020)10.1182/blood.2020006964

N/A

0DataRank · unranked

146 citations

Ted Gooley, Kelly A. Sweerus, Cynthia L. Maree, Neil A. Bailey, Megumi Bailey +15 more

Krish Patel

Indexed papers

Top data-sharing exemplar

Papers